ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Allegra-d 12 Hour Allergy And Congestion, and when can generic versions of Allegra-d 12 Hour Allergy And Congestion launch?
Allegra-d 12 Hour Allergy And Congestion is a drug marketed by Chattem Sanofi and is included in one NDA.
The generic ingredient in ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION is fexofenadine hydrochloride; pseudoephedrine hydrochloride. There are twenty-three drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the fexofenadine hydrochloride; pseudoephedrine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allegra-d 12 Hour Allergy And Congestion
A generic version of ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION was approved as fexofenadine hydrochloride; pseudoephedrine hydrochloride by DR REDDYS LABS LTD on June 22nd, 2011.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION?
- What are the global sales for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION?
- What is Average Wholesale Price for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION?
Summary for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 2 |
Patent Applications: | 69 |
DailyMed Link: | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION at DailyMed |
Pharmacology for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
Drug Class | Histamine-1 Receptor Antagonist alpha-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020786-002 | Jan 24, 2011 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chattem Sanofi | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020786-002 | Jan 24, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020786-002 | Jan 24, 2011 | ⤷ Sign Up | ⤷ Sign Up |
Chattem Sanofi | ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION | fexofenadine hydrochloride; pseudoephedrine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020786-002 | Jan 24, 2011 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION
See the table below for patents covering ALLEGRA-D 12 HOUR ALLERGY AND CONGESTION around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 679910 | ⤷ Sign Up | |
Spain | 2121084 | ⤷ Sign Up | |
Australia | 725811 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |